Disc Medicine Initiates BEACON, a Phase 2 Clinical Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP)

BEACON study will evaluate bitopertin as a potential disease-modifying treatment for patients with Erythropoietic Protoporphyria (EPP) or X-linked Protoporphyria (XLP) Key assessments include changes in protoporphyrin IX levels, safety, tolerability…

Forgoing animal experiments: a case study in intervertebral disc regenerative medicine | Centre for Bioengineering and Biotechnology

Abstracts The intervertebral disc (IVD), a fibro-cartilaginous structure acting as a natural shock absorber, contains an outer network of collagen fibers (annulus fibrosus) surrounding a central gelatinous (nucleus pulposus). Low…